The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Diagnosis and Treatment of Ovarian Cancer
Abstract
Epithelial ovarian cancer classically presents with vague persistent gastrointestinal, urologic, or nonacute abdominal/pelvic symptoms (bloating, early satiety, discomfort). Ultimately, a pelvic examination or imaging identifies an adnexal mass typically with accompanied advanced peritoneal dissemination. Management involves aggressive cytoreductive surgery in combination with platinum and taxane chemotherapy. Over the last 20 years, optimal resection and mode and timing of chemotherapy have evolved. The authors review the initial diagnosis and management and present the available data and recommendations to guide the decision tree of when to use neoadjuvant, intraperitoneal, HIPEC, dose-dense, and maintenance chemotherapy in the front-line treatment of epithelial ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,625
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Vergote, I., Tropé, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., Verheijen, R. H. M., van der Burg, M. E. L., Lacave, A. J., Panici, P. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908806 · Cited by 2,537
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Burger, R. A., Brady, M. F., Bookman, M. A., Fleming, G. F., Monk, B. J., Huang, H., Mannel, R. S., Homesley, H. D., Fowler, J., Greer, B. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104390 · Cited by 2,404
Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L., & Montz, F. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1248 · Cited by 2,312
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103799 · Cited by 2,172
Verwaal, V. J., van Ruth, S., de Bree, E., van Slooten, G. W., van Tinteren, H., Boot, H., & Zoetmulder, F. A. N. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.187 · Cited by 2,049
Ozols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., Mannel, R. S., DeGeest, K., Hartenbach, E. M., & Baergen, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.153 · Cited by 2,032
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
van Driel, W. J., Koole, S. N., Sikorska, K., Schagen van Leeuwen, J. H., Schreuder, H. W. R., Hermans, R. H. M., de Hingh, I. H. J. T., van der Velden, J., Arts, H. J., Massuger, L. F. A. G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1708618 · Cited by 1,426
Kehoe, S., Hook, J., Nankivell, M., Jayson, G. C., Kitchener, H., Lopes, T., Luesley, D., Perren, T., Bannoo, S., Mascarenhas, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62223-6 · Cited by 1,414
Alberts, D. S., Liu, P. Y., Hannigan, E. V., O'Toole, R., Williams, S. D., Young, J. A., Franklin, E. W., Clarke-Pearson, D. L., Malviya, V. K., DuBeshter, B., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352603 · Cited by 1,228
du Bois, A. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg036 · Cited by 1,113
Markman, M., Bundy, B. N., Alberts, D. S., Fowler, J. M., Clark-Pearson, D. L., Carson, L. F., Wadler, S., & Sickel, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1001 · Cited by 1,080
Piccart, M. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.699 · Cited by 981
Oza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00086-8 · Cited by 875
Bookman, M. A., Brady, M. F., McGuire, W. P., Harper, P. G., Alberts, D. S., Friedlander, M., Colombo, N., Fowler, J. M., Argenta, P. A., De Geest, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1684 · Cited by 705
Ovarian cancer: Epidemiology, biology, and prognostic factors
Holschneider, C. H., & Berek, J. S. (2000) · Seminars in Surgical Oncology · doi:10.1002/1098-2388(200007/08)19:1<3::aid-ssu2>3.0.co;2-s · Cited by 694
Trimbos, J. B., Vergote, I., Bolis, G., Vermorken, J. B., Mangioni, C., Madronal, C., Franchi, M., Tateo, S., Zanetta, G., Scarfone, G., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.113 · Cited by 674
Hoskins, W. J., McGuire, W. P., Brady, M. F., Homesley, H. D., Creasman, W. T., Berman, M., Ball, H., & Berek, J. S. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70090-7 · Cited by 659
Vasey, P. A., Jayson, G. C., Gordon, A., Gabra, H., Coleman, R., Atkinson, R., Parkin, D., Paul, J., Hay, A., Kaye, S. B., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh323 · Cited by 632
Muggia, F. M., Braly, P. S., Brady, M. F., Sutton, G., Niemann, T. H., Lentz, S. L., Alvarez, R. D., Kucera, P. R., & Small, J. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.106 · Cited by 601
Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.013 · Cited by 596
Young, R. C., Walton, L. A., Ellenberg, S. S., Homesley, H. D., Wilbanks, G. D., Decker, D. G., Miller, A., Park, R., & Major, F. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004123221501 · Cited by 583
(1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)90219-8 · Cited by 553
Hoskins, W. J., Bundy, B. N., Thigpen, J. T., & Omura, G. A. (1992) · Gynecologic Oncology · doi:10.1016/0090-8258(92)90100-w · Cited by 544
Katsumata, N., Yasuda, M., Isonishi, S., Takahashi, F., Michimae, H., Kimura, E., Aoki, D., Jobo, T., Kodama, S., Terauchi, F., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70363-2 · Cited by 480
(ICON1), I. C. O. N. 1., & European Organisation for Research and Treatment of Cancer Collaborators–Adjuvant ChemoTherapy In Ovarian Neoplasm (EORTC–ACTION) (2003) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.105 · Cited by 443
Fagotti, A., Ferrandina, G., Vizzielli, G., Fanfani, F., Gallotta, V., Chiantera, V., Costantini, B., Margariti, P. A., Gueli Alletti, S., Cosentino, F., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.01.017 · Cited by 395
Pignata, S., Scambia, G., Katsaros, D., Gallo, C., Pujade-Lauraine, E., De Placido, S., Bologna, A., Weber, B., Raspagliesi, F., Panici, P. B., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70049-x · Cited by 389
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
Chan, J. K., Brady, M. F., Penson, R. T., Huang, H., Birrer, M. J., Walker, J. L., DiSilvestro, P. A., Rubin, S. C., Martin, L. P., Davidson, S. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505067 · Cited by 367
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer
Jaaback, K., Johnson, N., & Lawrie, T. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005340.pub4 · Cited by 359
[Prognostic factors in patients with stage I epithelial ovarian cancer].
Wen, H. W., & Liu, S. W. (1994) · PubMed · Cited by 353
Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer
du Bois, A., Floquet, A., Kim, J.-W., Rau, J., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Vergote, I., Colombo, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.7348 · Cited by 328
Fagotti, A., Ferrandina, G., Fanfani, F., Garganese, G., Vizzielli, G., Carone, V., Salerno, M. G., & Scambia, G. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.052 · Cited by 315
Bell, J., Brady, M. F., Young, R. C., Lage, J., Walker, J. L., Look, K. Y., Rose, G. S., & Spirtos, N. M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.013 · Cited by 307
Prognostic factors in patients with stage I epithelial ovarian cancer.
Dembo, A. J., Davy, M., Stenwig, A. E., et al. (1990) · PubMed · Cited by 291
Tewari, D., Java, J. J., Salani, R., Armstrong, D. K., Markman, M., Herzog, T., Monk, B. J., & Chan, J. K. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9898 · Cited by 288
ICON1 (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.125 · Cited by 287
Horowitz, N. S., Miller, A., Rungruang, B., Richard, S. D., Rodriguez, N., Bookman, M. A., Hamilton, C. A., Krivak, T. C., & Maxwell, G. L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.3106 · Cited by 252
DISTRIBUTION OF INTRA-ABDOMINAL MALIGNANT SEEDING: DEPENDENCY ON DYNAMICS OF FLOW OF ASCITIC FLUID
MEYERS, M. A. (1973) · American Journal of Roentgenology · doi:10.2214/ajr.119.1.198 · Cited by 250
Endometriosis and ovarian cancer: Thoughts on shared pathophysiology
Ness, R. B. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.408 · Cited by 229
Pignata, S., Scambia, G., Ferrandina, G., Savarese, A., Sorio, R., Breda, E., Gebbia, V., Musso, P., Frigerio, L., Del Medico, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8566 · Cited by 229
Ovarian cancer risk associated with varying causes of infertility
Brinton, L. A., Lamb, E. J., Moghissi, K. S., Scoccia, B., Althuis, M. D., Mabie, J. E., & Westhoff, C. L. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.109 · Cited by 225
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
Morrison, J., Haldar, K., Kehoe, S., & Lawrie, T. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005343.pub3 · Cited by 223
Vencken, P. M. L. H., Kriege, M., Hoogwerf, D., Beugelink, S., van der Burg, M. E. L., Hooning, M. J., Berns, E. M., Jager, A., Collée, M., Burger, C. W., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq628 · Cited by 212
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
Wright, A. A., Cronin, A., Milne, D. E., Bookman, M. A., Burger, R. A., Cohn, D. E., Cristea, M. C., Griggs, J. J., Keating, N. L., Levenback, C. F., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4776 · Cited by 185
Chi, D. S., Abu-Rustum, N. R., Sonoda, Y., Ivy, J., Rhee, E., Moore, K., Levine, D. A., & Barakat, R. R. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.018 · Cited by 183
Chua, T. C., Robertson, G., Liauw, W., Farrell, R., Yan, T. D., & Morris, D. L. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0667-4 · Cited by 176
Skates, S. J., Greene, M. H., Buys, S. S., Mai, P. L., Brown, P. H., Piedmonte, M., Rodriguez, G. C., Schorge, J. O., Sherman, M. E., Daly, M. B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2750 · Cited by 154
Self-citationD, M. D. M., Kusamura, S., Virzì, S., Puccio, F., Macrì, A., Famulari, C., Solazzo, M., Bonomi, S., Iusco, D. R., & Baratti, D. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.05.004 · Cited by 149
Chan, J. K., Tian, C., Fleming, G. F., Monk, B. J., Herzog, T. J., Kapp, D. S., & Bell, J. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.10.073 · Cited by 148
Rutten, M. J., van Meurs, H. S., van de Vrie, R., Gaarenstroom, K. N., Naaktgeboren, C. A., Gorp, T. V., ter Brugge, H. G., Hofhuis, W., Schreuder, H. W. R., Arts, H. J. G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.2962 · Cited by 148
Tewari, K. S., Java, J., Eskander, R. N., Monk, B. J., & Burger, R. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv500 · Cited by 140
Laparoscopy versus laparotomy for FIGO stage I ovarian cancer
Falcetta, F. S., Lawrie, T. A., Medeiros, L. R., da Rosa, M. I., Edelweiss, M. I. A., Stein, A. T., Zelmanowicz, A. D. M., de Moraes, A. B., Zanini, R. R., Rosa, D. D., et al. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005344.pub4 · Cited by 137
A framework for a personalized surgical approach to ovarian cancer
Nick, A. M., Coleman, R. L., Ramirez, P. T., & Sood, A. K. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.26 · Cited by 131
Vergote, I. B., Jimeno, A., Joly, F., Katsaros, D., Coens, C., Despierre, E., Marth, C., Hall, M., Steer, C., Colombo, N., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.5669 · Cited by 121
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Vergote, I. B., Chiva, L., & du Bois, A. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1802033 · Cited by 118
Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis
Park, H. J., Kim, D., Yim, G. W., Nam, E. J., Kim, S., & Kim, Y. T. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.04.013 · Cited by 109
Survival in Women With Grade 1 Serous Ovarian Carcinoma
Fader, A. N., Java, J., Ueda, S. M., Bristow, R. E., Armstrong, D. K., Bookman, M. A., & Gershenson, D. M. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31829ce7ec · Cited by 109
Prevention and Early Detection of Ovarian Cancer: Mission Impossible?
Bast, R. C., BREWER, M. A., Zou, C., Hernandez, M. A., Daley, M., Ozols, R. F., Lu, K. H., Lü, Z., Badgwell, D. B., Mills, G. B., et al. (2007) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-37696-5_9 · Cited by 106
Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer
Rutten, M. J., Leeflang, M., Kenter, G. G., Mol, B. W., & Buist, M. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009786.pub2 · Cited by 103
Serous tubal intraepithelial neoplasia: the concept and its application
Meserve, E. E. K., Brouwer, J., & Crum, C. P. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.238 · Cited by 97
Fader, A. N., Java, J., Tenney, M. E., Ricci, S., Gunderson, C. C., Temkin, S. M., Spirtos, N. M., Kushnir, C. L., Pearl, M. L., Zivanovic, O., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.10.016 · Cited by 96
Maintenance chemotherapy for ovarian cancer
Mei, L., Chen, H., Wei, D. M., Fang, F., Liu, G. J., Xie, H. Y., Wang, X., Zhou, J., & Feng, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007414.pub3 · Cited by 95
Giorgio, A. D., Iaco, P. D., Simone, M. D., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5686-1 · Cited by 95
Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
Vergote, I. B., Wever, I. D., Decloedt, J., Tjalma, W. A. A., van Gramberen, M., & van Dam, P. A. (2000) · PubMed · Cited by 92
Symptoms Associated With Ovarian Cancer
Goff, B. A. (2012) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3182480523 · Cited by 91
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Cheng, X., Zhang, L., Chen, Y., & Qing, C. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0369-5 · Cited by 80
Ovarian Cancer Incidence Among Asian Migrants to the United States and Their Descendants
Herrinton, L., Stanford, J. L., Schwartz, S. M., & Weiss, N. S. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.17.1336 · Cited by 78
Provencher, D. M., Gallagher, C., Parulekar, W. R., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx754 · Cited by 65
Clamp, A. R., McNeish, I. A., Dean, A. P., Gallardo, D., Weon-Kim, J., O’Donnell, D. M., Hook, J., Coyle, C., Blagden, S. P., Brenton, J. D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx440.039 · Cited by 51
Laparoscopy versus laparotomy for FIGO stage I ovarian cancer
Lawrie, T. A., Medeiros, L. R., Rosa, D. D., da Rosa, M. I., Edelweiss, M. I. A., Stein, A. T., Zelmanowicz, A. D. M., de Moraes, A. B., & Zanini, R. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005344.pub3 · Cited by 47
Early-Stage Ovarian Cancer: To Treat or Not To Treat
Young, R. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.94 · Cited by 42
Laparoscopic surgical staging of early ovarian cancer.
Weber, S. M., McCann, C. K., Boruta, D. M., Schorge, J. O., & Growdon, W. B. (2011) · PubMed · Cited by 40
Stage IV ovarian cancer: Disease site-specific rationale for postoperative treatment
Aletti, G. D., Podratz, K. C., Cliby, W. A., & Gostout, B. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.09.010 · Cited by 39
Edwards, R. P., Huang, X., & Vlad, A. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1002732 · Cited by 35
Self-citationBrockbank, E. C., Harry, V. N., Kolomainen, D., Mukhopadhyay, D., Sohaib, A., Bridges, J. E., Nobbenhuis, M., Shepherd, J. H., Ind, T. E. J., & Barton, D. P. J. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.05.007 · Cited by 33
Kolomainen, D. F., A’Hern, R., Coxon, F. Y., Fisher, C., King, D. M., Blake, P., Barton, D. P. J., Shepherd, J. H., Kaye, S. B., & Gore, M. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.119 · Cited by 32
Nakagawa, N., Kouda, H., Nitta, N., Nakahara, Y., Uno, J., Hashimoto, T., Nakahori, T., Hasegawa, M., & Kataoka, M. (2015) · PubMed · doi:10.18926/amo/53559 · Cited by 24
Cited by
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566511 · Cited by 392
Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer (Review)
Yang, L., Xie, H.-J., Li, Y.-Y., Wang, X., Liu, X.-X., & Mai, J. (2022) · Oncology Reports · doi:10.3892/or.2022.8293 · Cited by 304
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
Coffman, L. G., Orellana, T. J., Liu, T., Frisbie, L. G., Normolle, D., Griffith, K., Uppal, S., McLean, K., Berger, J., Boisen, M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160573 · Cited by 17
Self-citation
Metadata
- Authors
- Orr, B., & Edwards, R. P.
- Venue
- Hematology/Oncology Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 32
- Issue
- 6
- Pages
- 943-964
- ISSN
- 0889-8588 (ISSN-L)
- OpenAlex
- W2898813162
- Cited by
- 322
- References
- 81
- FWCI
- 20.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.